Research2026 · Arts & Mental Health Journal
Published: world-first objective cognitive framework
A short look at what's changing in cognitive healthcare and what it means for patients.
Transforming Brain Health
EarlierDetection.BetterOutcomes.SmarterCognitiveCare.
NeuroInsights is a world-first objective framework using AI-driven behavioural analysis to accelerate diagnosis of neurological conditions — collapsing 18+ month timelines and unlocking up to £30bn in healthcare savings.
Cognitive Index
0/100
▲ Risk profile improving
Live Assessment
The Challenge
Neurological conditions are now the leading cause of illness and disability worldwide — 1 in 3 people affected.
World Health Organisation, March 2024
£0bn
Annual cost to the NHS & UK economy from delayed dementia diagnosis alone
0 months+
Lengthy, fragmented diagnosis pathway — 2-5 GP visits before referral
£0bn
Potential savings unlocked by earlier, objective cognitive detection
The Problem
Today's cognitive pathway is broken.
- 01
No objective framework
Healthcare providers, doctors and pharma lack a way to objectively track cognitive function or drug efficacy.
- 02
18+ month diagnosis
Lengthy, fragmented pathway with 2-5 GP appointments before specialist referral.
- 03
Acute admissions surge
Late detection drives hospital stays, social care needs and downstream cost.
- 04
Emotional & financial strain
Patients and families navigate uncertainty for over a year before answers.
- 05
300+ conditions affected
From ADHD to dementia, cognitive function underpins hundreds of neurological conditions.
The Solution
A world-first objective framework.
A fitness tracker for your brain.
NeuroInsights tracks attention, memory, language, executive function, perceptual motor function and social cognition — passively, continuously, and privately on the user's own device.
A
ASSESS
Passive audio & video capture across natural daily interactions — no clinic visit required.
A
ANALYSE
AI maps 40+ digital biomarkers across 6 cognitive domains.
B
BENCHMARK
Each user measured against their own personal baseline — not population norms.
A
ACT
Personalised insights and tailored strategies delivered when they matter.
Platform Showcase
From a £9.99 consumer subscription to NHS-wide deployment.
neuroinsights.app / clinician
Patients today
0
Flagged for review
0
Urgent
0
Cohort cognitive trajectory
Patient
Margaret R.
Age 68 · Annual review
Memory88
Attention76
Executive91
Today's session
Cognitive check
0%
3 of 4 modules complete
Why CHT is different
Engineered for trust. Designed for scale.
World-First Framework
Co-created with Dr Christian Morgner at the University of Sheffield, aligned to NICE guidelines.
40 Indicators, 6 Domains
Attention, memory, language, executive function, perceptual motor & social cognition.
Designed by Neurodiverse Minds
Built with lived experience to minimise stigma, cognitive load and emotional strain.
Patent-Pending Privacy
End-to-end encrypted, on-device passive capture — comprehensive cybersecurity by design.
Evidence
Built on rigorous clinical foundations.
2020
Concept founded
Victoria Burnip founds Unforgettable Experiences in partnership with Dr Christian Morgner, University of Sheffield.
2021
World-first framework
Objective measurement framework co-created with clinicians in mental health, dementia and neurology, aligned to NICE.
2022
Academic validation
Piloted as an objective measurement tool in world-first research (2021-2022).
2026
Peer-reviewed publication
Research published following peer review in the Arts and Mental Health Journal.
2026
Beta & NHS pilot
Beta app live, DTAC submission, NHS pilot underway.
2027
Clinical trial & UKCA
NHS clinical trial in partnership, UKCA/MHRA registration.
Market Opportunity
£96 billion at stake. A category-defining opportunity.
Dual-track go-to-market: £9.99/month B2C subscription scaling alongside NHS B2B2C pilots at £295k ARR per 3-PCN cluster.
UK Cost Burden
£0bn
Annual NHS & UK economy cost from delayed diagnosis
B2C Beachhead
0k
Diagnosed ADHD adults in England — initial segment
Conditions Affected
0+
Conditions impacting cognitive function globally
Investment Raise
£0k
£176k secured · £424k to raise
Applications
Wherever cognitive care is delivered.
NHS & ICBs
Tailored cognitive intelligence
Memory Clinics
Tailored cognitive intelligence
ADHD & Neurodiversity
Tailored cognitive intelligence
Dementia Pathways
Tailored cognitive intelligence
Pharma Drug Efficacy
Tailored cognitive intelligence
Occupational Health
Tailored cognitive intelligence
Private Healthcare
Tailored cognitive intelligence
International Health Systems
Tailored cognitive intelligence
Leadership
A team building what's next in brain health.
Victoria Burnip
Founder & CEO
Prof. Christian Morgner
Chief Scientific Officer
Rob Boville
Chief Technology Officer
CA
Clinical Advisory Board
Lived Experience & Clinical
News & Insights
Notes from the future of cognitive care.
PolicyMajor Conditions Strategy
NHS mandate: 92% of dementia referrals within 18 weeks by 2029
A short look at what's changing in cognitive healthcare and what it means for patients.
ScienceClinical Insight
Why ADHD adults are 3× more likely to develop dementia
A short look at what's changing in cognitive healthcare and what it means for patients.
Join Us
Reimagining the future of brain health.
Join us in delivering earlier detection, better outcomes and a smarter future for cognitive care.
